V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280005578 | 280003541 | 1.72 | 69.5 | Disease modification (D) | 2013-10-17 | 2013-10-17 | PACLITAXEL | 02 | N | 280029334 | LANREOTIDE |
| 280005579 | 280003541 | 0.7 | 89.2 | Palliative (P) | 2017-09-13 | 2017-10-22 | CompARE Trial | 02 | N | 280029334 | CAPECITABINE + OXALIPLATIN |
| 280005580 | 280003542 | 1.76 | 70.2 | Palliative (P) | 2016-04-02 | 2016-04-12 | Streptozocin + MdG | 2 | N | 280029346 | CAPECITABINE + OXALIPLATIN |
| 280005581 | 280003542 | 1.82 | 72.4 | Palliative (P) | 2016-03-22 | 2016-04-02 | CHOP R - 21 days | 02 | N | 280029346 | ECX |
| 280005582 | 280010018 | 1.73 | 78.6 | Palliative (P) | 2014-07-09 | 2014-07-10 | Imatinib 400mg | 2 | N | 280029349 | CAPECITABINE + OXALIPLATIN |
| 280005583 | 280010018 | 0 | 91.6 | Palliative (P) | 2014-04-08 | 2014-04-14 | ABVD | N | N | 280029349 | GEMCARBO |
| 280005584 | 280003543 | 1.73 | 80 | Palliative (P) | 2014-05-19 | 2014-05-24 | OCTREOTIDE | 02 | N | 280029352 | GEMCARBO |
| 280005585 | 280003544 | null | 88.35 | Neo-adjuvant (N) | 2017-04-02 | 2017-04-04 | ECX | N | N | 280029353 | OCTREOTIDE |
| 280005586 | 280003545 | null | null | Neo-adjuvant (N) | null | 2014-01-15 | ETOPOSIDE | null | null | 280029355 | OXALIPLATIN + MDG |
| 280005587 | 280003545 | 1.62 | 58 | Palliative (P) | 2016-05-20 | 2016-05-20 | OCTREOTIDE | 2 | N | 280029355 | CAPECITABINE + OXALIPLATIN |
| 280005588 | 280003546 | null | null | null | 2016-05-08 | 2016-05-13 | LANREOTIDE | N | N | 280029358 | GEMCITABINE |
| 280005589 | 280007889 | 1.69 | 83.2 | null | 2017-09-03 | 2017-09-10 | Abiraterone | N | N | 280029359 | ERLOTINIB |
| 280005590 | 280010019 | 1.8 | 67.9 | Palliative (P) | 2017-09-08 | 2017-09-14 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | N | 280029362 | GEMCARBO |
| 280005591 | 280010019 | 1.8 | null | null | 2017-06-28 | 2017-07-10 | Bortezomib + Cyclophos + Dex | N | N | 280029362 | MITOMYCIN INTRAVESICULAR |
| 280005592 | 280003547 | 1.77 | 80.3 | Palliative (P) | 2015-12-06 | 2015-12-08 | GemCarbo Days 1+8 | 2 | N | 280029365 | DOXORUBICIN + OLARATUMAB |
| 280005593 | 280003547 | 1.75 | 91.65 | Palliative (P) | 2015-09-12 | 2015-10-13 | Dacarbazine | N | Y | 280029365 | GEMCARBO |
| 280005594 | 280003547 | 1.65 | 59.6 | Palliative (P) | 2017-07-07 | 2017-07-12 | KESTREL Trial | N | N | 280029365 | CAPECITABINE + OXALIPLATIN |
| 280005595 | 280003547 | 1.68 | 110.7 | Disease modification (D) | 2014-09-17 | 2014-09-21 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 280029365 | GEMCARBO |
| 280005596 | 280003548 | 1.66 | 0 | Curative (C) | 2013-10-05 | 2013-10-05 | Chlorambucil | 02 | N | 280029373 | EURO-EWING |
| 280005597 | 280003548 | 1.7 | 101.5 | Palliative (P) | 2016-10-25 | 2016-10-25 | BCG Intravesical | N | N | 280029373 | DOCETAXEL + GEMCITABINE |
| 280005598 | 280003549 | 1.64 | 57.1 | Palliative (P) | 2016-02-16 | 2016-02-21 | Cisplatin + Pemetrexed | N | N | 280029375 | DOXORUBICIN + OLARATUMAB |
| 280005599 | 280007892 | 1.82 | 70.4 | Curative (C) | 2015-09-27 | 2015-10-23 | Abiraterone | N | N | 280029376 | DARS TRIAL |
| 280005600 | 280007892 | 1.74 | null | Disease modification (D) | 2017-12-15 | 2017-12-19 | Cisplatin + Docetaxel | null | null | 280029376 | TCF |
| 280005601 | 280003550 | 1.69 | null | Curative (C) | 2015-03-01 | 2015-03-04 | DACTINOMYCIN + CYCLO + VINCRISTINE | null | null | 280029380 | CISPLATIN + ETOPOSIDE |
| 280005602 | 280003550 | 1.7 | 109.9 | Palliative (P) | 2016-04-24 | 2016-04-24 | CARBOPLATIN + VINORELBINE | 02 | N | 280029380 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 280005603 | 280003551 | 1.64 | 78.8 | null | null | 2017-12-17 | EpSSG NRSTS 2005 | null | null | 280029382 | DE-ESCALATE TRIAL |
| 280005604 | 280003551 | 1.76 | 87.5 | Adjuvant (A) | 2016-10-06 | 2016-10-06 | Carboplatin+Fluorouracil 4 or 5 day | 2 | N | 280029382 | CISPLATIN + DOXORUBICIN |
| 280005605 | 280003551 | 1.7 | 100.1 | null | null | 2016-05-30 | VIDE | null | null | 280029382 | MITOMYCIN |
| 280005606 | 280003551 | null | 61.8 | Palliative (P) | 2017-05-23 | 2017-05-27 | Everolimus 10mg | 02 | N | 280029382 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 280005607 | 280003551 | 1.7 | 102 | Palliative (P) | 2015-04-24 | 2015-05-18 | Cisplatin + Docetaxel | 02 | Y | 280029382 | LIPOSOMAL DOXORUBICIN |
| 280005608 | 280003551 | 1.56 | null | null | 2017-10-29 | 2017-10-31 | Cisplatin + Fluorouracil + RT 5day | N | N | 280029382 | PACLITAXEL |
| 280005609 | 280003551 | 1.75 | 82.7 | Palliative (P) | 2013-04-28 | 2013-05-16 | Irinotecan + Modified De Gramont | N | N | 280029382 | DOXORUBICIN + OLARATUMAB |
| 280005610 | 280003552 | 1.65 | null | null | 2016-06-25 | 2016-06-27 | STS Rhabdomyosarcoma RMS 2005 IVADo | 02 | null | 280029397 | DACTINOMYCIN + DOXO + IFOS + VINCRISTINE |
| 280005611 | 280003553 | 1.55 | null | Neo-adjuvant (N) | null | 2013-10-11 | Cisplatin + Fluorouracil + RT 5day | null | null | 280029398 | EURO-EWING |
| 280005612 | 280003553 | 1.7 | 12.4 | Curative (C) | 2017-11-22 | 2017-11-24 | Capecitabine | 02 | N | 280029398 | CVD |
| 280005613 | 280003553 | 1.7 | 60.8 | Palliative (P) | 2018-09-28 | 2018-09-30 | Cisplatin + Vinorelbine (PO) | null | null | 280029398 | CAV |
| 280005614 | 280003554 | 1.74 | null | Palliative (P) | 2017-04-20 | 2017-04-23 | PACLITAXEL | 02 | Y | 280029405 | CARBOPLATIN + CETUXIMAB + FU |
| 280005615 | 280007896 | 1.82 | null | Curative (C) | 2015-01-05 | 2015-01-27 | IMATINIB | N | N | 280029407 | CISPLATIN + FLUOROURACIL + RT |
| 280005616 | 280007896 | 0 | 101.9 | Palliative (P) | 2014-07-19 | 2014-07-19 | ECX | 2 | N | 280029407 | IVADO |
| 280005617 | 280003555 | 1.7 | 90 | Palliative (P) | 2017-05-10 | 2017-05-16 | Capecitabine + Oxaliplatin 21day | N | N | 280029412 | TRABECTEDIN |
| 280005618 | 280003556 | 1.8 | 65 | Palliative (P) | 2014-01-09 | 2014-01-24 | Vemurafenib | N | N | 280029413 | PAZOPANIB |
| 280005619 | 280003556 | 1.63 | 40.6 | null | 2018-01-20 | 2018-01-26 | FCiSt | 02 | N | 280029413 | CARBOPLATIN + PACLITAXEL + RT |
| 280005620 | 280003557 | 1.73 | null | Adjuvant (A) | 2016-01-20 | 2016-02-02 | Abiraterone | N | N | 280029415 | CISPLATIN + VINORELBINE |
| 280005621 | 280003557 | 1.83 | 69.4 | Palliative (P) | 2015-08-06 | 2015-08-07 | INTERFERON | N | N | 280029415 | PACLITAXEL |
| 280005622 | 280003557 | 1.5 | 57 | Adjuvant (A) | 2013-12-01 | 2013-12-03 | Docetaxel + Gemcitabine (prior RT) | 02 | N | 280029415 | CAPECITABINE |
| 280005623 | 280003558 | 1.8 | 65.3 | Palliative (P) | 2014-09-21 | 2014-09-25 | Ipilimumab | 02 | null | 280029420 | PACLITAXEL |
| 280005624 | 280003559 | 1.61 | 57.4 | Neo-adjuvant (N) | 2017-03-11 | 2017-03-31 | Doxorubicin + Olaratumab | 2 | N | 280029421 | CAV |
| 280005625 | 280003560 | 1.85 | 86.5 | Curative (C) | 2013-12-31 | 2014-01-01 | Doxorubicin + Olaratumab | 02 | Y | 280029422 | EURO-EWING |
| 280005626 | 280003560 | 1.69 | 70.6 | Adjuvant (A) | 2018-01-13 | 2018-01-31 | Mitomycin Intravesical | 02 | N | 280029422 | CARBO + FLUOROURACIL |
| 280005627 | 280003561 | 1.8 | 46.6 | Adjuvant (A) | 2014-11-19 | 2014-11-19 | IRINOTECAN + TEMOZOLOMIDE + VINCRISTINE | N | N | 280029425 | CAPECITABINE |